Hedge Fund Database
The curated database of hedge funds that publish investor letters. Research by geography, strategy, and schools of thought.
| # | Fund | Strategy | Style | Geography | AUM | Latest Letter |
|---|---|---|---|---|---|---|
The curated database of hedge funds that publish investor letters. Research by geography, strategy, and schools of thought.
| # | Fund | Strategy | Style | Geography | AUM | Latest Letter |
|---|---|---|---|---|---|---|
As of Aug 14, 2026
Rivemont's portfolio is positioned for a great sector rotation in 2026, diverging significantly from major market indices. The manager draws parallels to the 2000-2001 period when the Nasdaq collapsed but Canadian resource and financial sectors rallied. The fund has aggressively overweighted healthcare, focusing on healthcare real estate, pharmaceuticals, and biotechnology, viewing the sector as more resilient and less volatile than broader markets. Holdings include Omega Healthcare, CareTrust, Jazz Pharmaceuticals, and Exelixis. Canadian financials represent the second major overweight, benefiting from near-monopoly positions that enable exceptional profit margins at reasonable valuations. Bank of Montreal and Manulife Financial are key holdings, with BMO gaining approximately 40% since January. The manager feels deeply connected to the market and expects continued outperformance while maintaining lower volatility. Cash remains somewhat elevated as the manager seeks deployment opportunities while prioritizing capital preservation. The fund has consistently delivered expected returns with lower volatility than the broader market.
The fund is positioned for a major sector rotation away from technology and AI toward overlooked sectors, particularly healthcare and Canadian financials, which offer resilience, lower volatility, and attractive valuations with strong profit margins.
The manager anticipates a great sector rotation in 2026, with renewed interest in sectors that have been overlooked during the technology and AI dominance. The manager feels deeply connected to the market and expects the coming years to favor healthcare and Canadian financials. Cash position remains somewhat higher than desired, and the manager is actively looking for opportunities to deploy capital while recognizing that preserving capital is sometimes as important as identifying new opportunities.
Moderate Conviction Bullish
Market Conviction
Growth Outlook
Risk Appetite
Capital Deployment
Forward Guidance
Language Signal
Perceived Risk
Opportunity Density
Time Horizon
Top Conviction Themes
Key Catalysts
Every insight in this database connects to the original source. Read the actual thesis, see the actual concerns, and make your own call.
Buyside Digest has no business relationship, partnership, agency, sponsorship, endorsement, or affiliation with Rivemont or any other manager whose content appears on the Service, except where expressly stated. We do not receive Manager Content directly from managers in most cases; content is collected from publicly available sources. Managers have not necessarily reviewed, approved, authorized, or endorsed our display of their content, our editorial commentary, our metadata extraction, or our classifications. Use of a manager’s name is for accurate attribution and identification purposes only, under principles of nominative fair use.
Buyside Digest does not independently verify the regulatory status, registrations, licensing, qualifications, credentials, or professional standing of managers whose content appears on the Service. We do not represent that managers are properly registered with applicable regulatory bodies, that their content complies with applicable securities laws, or that their performance representations are accurate. Inclusion of a manager in our database is based on the publicly available nature of their content, not on our verification of their regulatory status or content compliance. Users are responsible for conducting their own due diligence on any manager.
Performance data, returns, assets under management (“AUM”), and similar figures displayed on this page are sourced from publicly available manager communications (including investor letters), public filings, or other third-party sources. Buyside Digest does not independently verify performance figures, calculate returns, or audit manager-reported data. Such figures: May be selectively reported by the manager; May use non-standard calculation methodologies; May not reflect fees, expenses, taxes, or other costs; May be inconsistent across reporting periods; May be outdated. Past performance is not indicative of future results. Performance figures should not be relied upon for investment decisions without independent verification. Users should request audited performance data directly from the manager and conduct their own due diligence.